You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 20, 2024

METAXALONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metaxalone patents expire, and what generic alternatives are available?

Metaxalone is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Ingenus Pharms Llc, Lannett Co Inc, Mountain, Primus Pharms, Rising, Sandoz, and Sciegen Pharms Inc. and is included in nine NDAs. There is one patent protecting this drug.

This drug has six patent family members in six countries.

The generic ingredient in METAXALONE is metaxalone. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the metaxalone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metaxalone

A generic version of METAXALONE was approved as metaxalone by SANDOZ on March 31st, 2010.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METAXALONE?
  • What are the global sales for METAXALONE?
  • What is Average Wholesale Price for METAXALONE?
Drug patent expirations by year for METAXALONE
Drug Prices for METAXALONE

See drug prices for METAXALONE

Drug Sales Revenue Trends for METAXALONE

See drug sales revenues for METAXALONE

Recent Clinical Trials for METAXALONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Illumination HealthPhase 4
Primus PharmaceuticalsPhase 4
Rothman Institute OrthopaedicsN/A

See all METAXALONE clinical trials

Pharmacology for METAXALONE
Paragraph IV (Patent) Challenges for METAXALONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SKELAXIN Tablets metaxalone 800 mg 013217 1 2004-11-04

US Patents and Regulatory Information for METAXALONE

METAXALONE is protected by one US patents.

Patents protecting METAXALONE


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc METAXALONE metaxalone TABLET;ORAL 203695-001 Jun 15, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising METAXALONE metaxalone TABLET;ORAL 208774-001 Sep 24, 2018 BX RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lannett Co Inc METAXALONE metaxalone TABLET;ORAL 204770-001 Nov 22, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz METAXALONE metaxalone TABLET;ORAL 040445-001 Mar 31, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms METAXALONE metaxalone TABLET;ORAL 203399-001 Jun 21, 2013 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for METAXALONE

See the table below for patents covering METAXALONE around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2020263768 ⤷  Sign Up
Australia 2020307390 Reduced dose metaxalone formulations ⤷  Sign Up
Japan 2022539368 低用量のメタキサロン製剤 ⤷  Sign Up
European Patent Office 3989946 FORMULATIONS DE MÉTAXALONE À DOSE RÉDUITE (REDUCED DOSE METAXALONE FORMULATIONS) ⤷  Sign Up
South Korea 20220025815 용량이 감소된 메탁살론 제형 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.